The fine control of short-range and long-range communication between cells requires mechanisms to create and modulate gradients of secreted signaling molecules (morphogens). The Wnt morphogens are secreted glycoproteins that bind to cell surface receptors so as to activate intracellular signaling pathways that are associated with embryonic development, oncogenesis and the differentiation of stem cells 1,2 . The most studied Wnt pathway, Wnt-β-catenin, is initiated when Wnt forms a ternary complex with the receptor Frizzled (Fzd) 3 and low-density lipoprotein receptor-related proteins 5 or 6 (LRP5/6) 4 . Wnt signaling is modulated by two broad classes of secreted extracellular proteins that interfere with the formation of the Fzd-Wnt-LRP5/6 complex 5 . Members of the Dickkopf (Dkk) class bind to LRP5/6 and prevent binding of the receptor to Wnt, whereas Cerberus, WIF-1 and members of the secreted Fzd-related protein (sFRP) family bind directly to Wnts and prevent them from triggering signaling.
a r t i c l e s
The fine control of short-range and long-range communication between cells requires mechanisms to create and modulate gradients of secreted signaling molecules (morphogens). The Wnt morphogens are secreted glycoproteins that bind to cell surface receptors so as to activate intracellular signaling pathways that are associated with embryonic development, oncogenesis and the differentiation of stem cells 1, 2 . The most studied Wnt pathway, Wnt-β-catenin, is initiated when Wnt forms a ternary complex with the receptor Frizzled (Fzd) 3 and low-density lipoprotein receptor-related proteins 5 or 6 (LRP5/6) 4 . Wnt signaling is modulated by two broad classes of secreted extracellular proteins that interfere with the formation of the Fzd-Wnt-LRP5/6 complex 5 . Members of the Dickkopf (Dkk) class bind to LRP5/6 and prevent binding of the receptor to Wnt, whereas Cerberus, WIF-1 and members of the secreted Fzd-related protein (sFRP) family bind directly to Wnts and prevent them from triggering signaling.
WIF-1 is present across vertebrate families and consists of an N-terminal secretion signal sequence, the WIF domain (WD, 143 amino acid residues), five EGF-like domains (31-33 residues each) and a hydrophilic C terminus (Fig. 1a) . Human WIF-1 binds through its WIF domain to eight Wnts (3a, 4, 5a, 7a, 9a, 11 (ref. 6 ), wingless and Xenopus Wnt8 (ref. 7) ) and a protein involved in neuronal differentiation, olfactomedin 1 (ref. 8) . The three-dimensional structure of refolded WIF-1 WD expressed in Escherichia coli was determined by NMR spectroscopy and revealed an interaction between a surface binding site on the WIF domain and alkyl chains of the detergent used during protein refolding 9 . This raised the question of whether the WIF domain can sequester Wnt3a-linked acyl chains 10, 11 . The role of the WIF-1 EGF-like domains is unknown. During embryogenesis in Xenopus and zebrafish, expression of WIF-1 is first detectable at the start of somitogenesis in the paraxial mesoderm 7 . WIF-1 expression continues in adults in the heart, lungs and cartilage-mesenchyme interfaces of various species 6, 7 . Deletion of the mouse WIF-1 gene accelerates the development of radiation-induced osteosarcomas in vivo 12 . Downregulation of WIF-1 expression by promoter methylation has been reported in human cancers 13 , and overexpression of WIF-1 inhibits the growth of cells from lung and bladder cancers 14, 15 .
How gradients of secreted morphogens such as Wnts and Hedgehogs (Hhs) are established and maintained is a key question 16 . Models of this process include covalent lipid modification co-localizing morphogens to cell membranes or lipoprotein particles, and morphogens interacting with the heparan sulfate glycosaminoglycans of HSPGs to modulate diffusion 17, 18 . The molecular mechanisms by which Wnt signaling is inhibited in lipoprotein particle-and HSPG-shaped morphogen gradients have remained poorly understood because lipid-modified Wnts 19 and their antagonists are difficult to purify in sufficient quantities for biochemical studies.
We set out to dissect the mechanisms by which WIF-1 interacts with Wnt3a and morphogen gradients using a series of WIF-1 constructs expressed in human embryonic kidney (HEK293) cells. When we determined the structure of four natively folded, glycosylated WIF domain-containing constructs, we found a tightly bound diacyl phosphatidylcholine-type lipid in the core of the WIF domain. Our structural analyses also suggested that the EGF-like domains can adopt a specific (wrapped back) position relative to the WIF domain. Structure-guided, site-directed mutagenesis in combination with biophysical and cellular assays showed that Wnt binds both to the WIF domain, in the vicinity of the phospholipid head group, and to the EGF-like domains, which also provided a HSPG-binding site. These findings lead us to conclude that the structure of WIF-1 allows the interactive characteristics of the WIF domain and EGF-like domains to synergize, and suggest a modular model for the function of WIF-1 in HSPG-shaped morphogen gradients.
RESULTS

WIF domain structure contains a lipid-binding pocket
We produced a series of human WIF-1 constructs (WIF-1 WD , WIF-1 WD-EGF-I , WIF-1 WD-EGFs I-III , WIF-1 ∆C , WIF-1 Full length and WIF-1 EGFs I-V ; Fig. 1a and Supplementary Figs. 1 and 2) . The crystal structures of WIF-1 WD and WIF-1 WD-EGF-I were determined to 1.85-Å resolution (see Online Methods and Table 1 ).
The WIF domain is essentially identical in the WIF-1 WD and WIF-1 WD-EGF-I structures (r.m.s. deviation of 0.17 Å between equivalent Cα atoms for 144 residues). The WIF domain fold consists of a β-sandwich splayed apart along one edge by insertion of three short helices (one 3 10 and two α-helices; Fig. 1b and Supplementary Fig. 3) . A ~10-Å gap between the α1 and 3 10 helices provides a gateway into a large cavity (1,515 Å 3 , calculated with CASTp 20 ), lined by primarily hydrophobic residues, which penetrates deep into the core of the WIF domain. Thus, the WIF domain lacks the close-packed interior of a standard β-sandwich. The β-sheets are locked together at the base of the sandwich by a disulfide bridge (Cys140-Cys177). Sequence alignments suggest this disulfide is conserved between species and is a canonical feature of the WIF domain fold when present in other proteins (Supplementary Fig. 3b ). In the WIF-1 WD-EGF-I structure, the EGF-like domain (EGF I) is connected to the WIF domain by a 4-residue linker and extends away from the WIF domain into solvent. The cysteine knot topology of EGF I is stabilized by the canonical three disulfide bridges. However, the structure of this domain appears relatively disordered compared to that of the WIF domain (as judged from crystallographic B-factors and quality of electron density), probably as a result of orientational flexibility relative to the WIF domain.
The crystal structures of the WIF domain described here differ markedly (r.m.s. deviation of 2.64 Å for 144 equivalent Cα atoms) from the previously reported WIF-1 WIF domain structure determined by solution NMR 9 ( Supplementary Fig. 4) . The WIF domain topology is largely identical between crystal and solution structures, but there is no cavity within the β-sandwich in the NMR structure: the two β-sheets form a close packed protein core. By contrast, the electron density maps for the WIF-1 WD and WIF-1 WD-EGF-I crystal structures show clear evidence for a lipid-like molecule bound as an integral part of the WIF domain core (Fig. 1c,d ). This additional molecule fills the large hydrophobic cavity, stabilizing the splayed-out conformation of the WIF domain β-sandwich. We used no supplemental lipids during protein production and crystallization, so the molecule must have been incorporated into the WIF-1 WIF domain during mammalian expression (the NMR structure was determined from protein expressed as inclusion bodies in E. coli and refolded 9 ). We extracted hydrophobic ligands from WIF-1 ∆C expressed in HEK293 cells and identified them by MS as a series of phosphatidylcholines (Fig. 1e) that differed in acyl chain length (C14-C18) and degree of saturation (C16:0-1, C18:0-1). The main species consists of two acyl chain lipids with 16 carbon atoms each-a chemistry that is typified by the common mammalian cell membrane lipid 1,2-dipalmitoylphosphatidylcholine (DPPC). DPPC refined successfully as part of the WIF-1 WD and WIF-1 WD-EGF-I crystal structures. The acyl chains fitted in an extended conformation snugly within the WIF domain core, filling the available volume of the pocket, whereas the phosphatidylcholine head group was exposed to the surface and interacted with three residues (Fig. 1b-d) . The ethylene group of the head group formed a hydrophobic interaction with Phe66, the glycerol backbone packed against Ile49 and the phosphatidyl oxygen made a hydrogen bond with Arg76 (Fig. 1c) .
The solution structure of the refolded human WIF domain indicated an association between the WIF domain and the alkyl chaincontaining detergent Brij-35 used in the refolding protocol 9 . This observation prompted the suggestion that the WIF-1 WIF domain might interact with the palmitoyl or palmitoleoyl chains linked to Cys77 and Ser209 of Wnt3a, respectively 10, 11 a r t i c l e s purified WIF-1 ∆C with a fluorescent lipid, 16:0 Liss Rhod PE (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) ammonium salt). Gel filtration revealed that WIF-1 ∆C and 16:0 Liss Rhod PE coeluted for a sample incubated in the presence of 1% CHAPS, suggesting that phosphatidylcholines bound within the core of the WIF domain, such as DPPC, could be exchanged in the presence of detergent ( Supplementary Fig. 5 ). Under similar conditions (including 1% CHAPS), we found no binding between WIF-1 ∆C (50 µM) and a fluorescent head group of 16:0 Liss Rhod PE alone (sulforhodamine B, 160 µM), consistent with the idea that the diacyl lipid chains of 16:0 Liss Rhod PE mediated its binding to WIF-1 ∆C . Finally, in the light of the detergent interaction mapped to the surface of the WIF-1 WIF domain in the solution NMR analysis 9 , we probed WIF-1 ∆C for surface-exposed lipid-binding sites using a lipid strip. We observed no binding of WIF-1 ∆C to any of 15 biologically abundant lipids in the absence of 1% CHAPS ( Supplementary Fig. 5f,g ). These analyses, in combination with the WIF domain structures of mammalian cell-expressed constructs, show that DPPC and closely related phosphatidylcholines act as physiological components of WIF-1 and saturate the lipid-binding capacity of the WIF domain. Sequence alignments indicate that the hydrophobic nature, and, in general, the size of the residues that line the lipid-binding pocket in the WIF-1 WIF domain are conserved in other WIF domain-containing proteins ( Supplementary Fig. 3b ), which suggests that phosphatidylcholines such as DPPC could be integral to WIF domains in general.
Wnt3a binding and inhibition by WIF and EGF-like domains
The WIF domain of WIF-1 is sufficient to inhibit Wnt signalling 7 , but the function of the five EGF-like domains (EGFs I-V) has remained obscure. We therefore used our series of WIF-1 constructs (Fig. 1a) in a Wnt response assay 21 to investigate the roles of the domains of WIF-1 in inhibition of Wnt3a. Wnt3a signaling was inhibited in a dose-dependent manner (33-500 nM; Fig. 2a ) by WIF-1 ∆C . WIF-1 WD and WIF-1 WD-EGF-I were also inhibitory, consistent with the previous report that the WIF domain in isolation can inhibit Wnt signaling 7 , but both these constructs were notably less effective than the molecules that contained the WIF domain and EGFs I-V. Thus, although EGFs I-V in isolation (construct WIF-1 EGFs I-V ) did not show pronounced inhibitory activity ( Fig. 2a) , the results of the cellular assays suggest that the EGF-like domains are involved in Wnt3a signal inhibition.
To analyze the biophysical basis of the difference in efficiency of Wnt3a inhibition by the WIF domain and molecules containing the WIF domain plus EGFs I-V, we probed the interactions between the different WIF-1 domains and Wnt3a using a surface plasmon resonance (SPR) binding assay ( Fig. 2b-f and Table 2 ). In agreement with the cellular assay, binding was tightest between Wnt3a and WIF-1 ∆C , with a dissociation constant (K d ) of 21.6 ± 8.0 nM. The full-length WIF-1 construct has a comparable binding affinity (K d 62.8 ± 23.3 nM), indicating that the hydrophilic C-terminal region makes no contribution to Wnt3a binding, consistent with a sequencebased prediction of flexibility (data not shown) and evolutionary divergence ( Supplementary Fig. 1 ). These SPR-based dissociation constants agree with a previously reported K d of 16 nM derived from platebased affinity assays for the interaction of Xenopus Wnt8 with human WIF-1 (ref. 7) . WIF-1 WD and WIF-1 WD-EGF-I bound much more weakly to Wnt3a (K d 3.4 ± 1.6 and 5.6 ± 2.4 µM, respectively). There was substantial binding affinity between WIF-1 EGFs I-V and Wnt3a (K d 0.9 ± 0.2 µM), suggesting that the differences in binding in the cellular assays resulted from a direct interaction between EGFs I-V and Wnt3a in addition to the interaction with the WIF domain. To provide further evidence of this additive effect, we tested an additional construct, WIF-1 WD-EGFs I-III , in the cellular and SPR assays ( Fig. 3a and Table 2 ). Again, binding and inhibition of Wnt3a were lower than for WIF-1 ∆C . This suggests that EGFs IV and V are necessary for the contribution of the EGF I-V unit to Wnt3a binding, but we cannot exclude the possibility that the reduced Wnt3a binding is an indirect effect arising from perturbation of EGF III because of the truncation at the EGF III-EGF IV interface (Supplementary Fig. 2c) . Together, the cellular and SPR binding assays are consistent with a modular model in which both the WIF domain and the EGF-like domains of WIF-1 interact with Wnt3a and contribute to signal inhibition.
The Wnt3a-binding site on the WIF domain We used our high-resolution crystal structures to identify suitable residues for mutagenesis to map out areas of the WIF domain surface that were involved in Wnt3a recognition. We individually mutated 15 surface-exposed sequences to introduce asparaginelinked glycosylation sites (Supplementary Fig. 6 ) and evaluated any resulting hindrance to WIF-1-Wnt3a recognition using the cellular assay ( Fig. 3a and Supplementary Fig. 7a ). We also used six additional single-residue mutations for finer-scale investigation a r t i c l e s of potential binding surfaces ( Fig. 3a and Supplementary Fig. 7b ).
Out of the 21 WIF-1 ∆C variants assayed, Phe174Asn and Phe51Asn Glu53Ser, for which the mutations were predicted to introduce N-linked glycosylation sites, and Met77Trp, a single point mutation, were the weakest inhibitors of Wnt3a signaling. In the context of WIF-1 ∆C , the Met77Trp mutation also showed a ten-fold decrease in binding affinity to Wnt3a in the SPR assay ( Table 2) . The chemical conversion of lysines to dimethyllysines 22 did not impair WIF-1 function ( Fig. 3a and Supplementary Fig. 7c ), suggesting that this modification does not interfere with the binding of Wnt3a. We also assessed the effect of sequence variation between species and found that zebrafish WIF-1 inhibited Wnt3a signaling as efficiently as the human ortholog ( Fig. 3a and Supplementary  Fig. 7d) , consistent with the Wnt3a-binding surface on WIF-1 being highly conserved. The combined results of the mutagenesis, lysine methylation and species variation analyses highlight a discontinuous but discrete area of the WIF domain surface as a putative Wnt3a-binding site (Fig. 3b,c) .
Within the putative Wnt3a-binding site, the effects of the Phe174Asn and Met77Trp variations on function highlight the region in the vicinity of the lipid head group (Fig. 3a,b) . Met77 is partially buried at the entrance to the lipid-binding cavity. To assess changes introduced by this mutation, we determined the crystal structure of WIF-1 WD-EGF-I Met77Trp at 2.22-Å resolution ( Table 1) . Superposition of the wildtype and mutant WIF-1 WD-EGF-I structures revealed no major longrange perturbations (r.m.s. deviation of 0.22 Å for 170 equivalent Cα atoms), and the acyl chains of the DPPC lipid remained buried within the core of the WIF domain. However, unlike the side chain of Met77, which makes no direct contact with the lipid in the wild-type structure, the tryptophan side chain in WIF-1 WD-EGF-I Met77Trp formed a hydrogen bond with a carbonyl oxygen of the palmitoyl tail group and the oxygen atom of the phosphatidylcholine head group, and the indole ring provided stacking interactions that further restricted the orientation of the lipid head group (Fig. 3d) . 
a r t i c l e s
We assessed whether lipid exchange was still possible in the presence of these stacking interactions and found that 16:0 Liss Rhod PE could still exchange the natively bound phosphatidylcholines (data not shown). Thus, the notable reduction in the ability of the WIF-1 Met77Trp mutant to inhibit Wnt3a signaling suggests that Met77 and the protein surface proximal to the lipid head group are involved in the Wnt3a-binding site. The involvement of the lipid may be indirect and the contribution of the head group is certainly limited; we could not inhibit the binding of wild-type WIF-1 WD-EGF-I to Wnt3a in SPR experiments using a 40-fold excess of the lipid head group analog phosphocholine ( Table 2 ).
The WIF-1 structure and orientation of the EGF-like domains
To investigate further the modular mechanism of Wnt signal inhibition, we determined the crystal structure of WIF-1 ∆C to 3.95-Å resolution ( Table 1) .The structure showed the lipid-containing WIF domain loosely wrapped by EGFs I-III, with EGFs IV and V extending away into the solvent (Fig. 4a,b) . The WIF domain retained the structure of WIF-1 WD (r.m.s. deviation of 0.53 Å for 143 equivalent Cα atoms) and DPPC again provided a suitable model for bound lipid density. The extended conformation of the acyl tails in the WIF domain lipidbinding cavity was conserved between the WIF-1 WD , WIF-1 WD-EGF-I and WIF-1 ∆C structures, but the position of the DPPC head group in WIF-1 ∆C deviated markedly from that observed for WIF-1 WD , WIF-1 WD-EGF-I and WIF-1 WD-EGF-I Met77Trp. The head group was oriented toward the C terminus of the WIF domain and the linker to EGF I in the WIF-1 ∆C structure, whereas it was oriented in essentially the opposite direction in the crystal structures of the shorter constructs (Fig. 4c) . This reorientation seems to occur because of differences in the packing of neighboring molecules in the various crystal lattices, suggesting that the orientation of the lipid head group can alter in response to external interactions. The second notable difference between the WIF-1 ∆C and WIF-1 WD-EGF-I structures is the relative orientation of EGF I and the WIF domain: EGF I was rotated by some 30° toward the WIF domain in WIF-1 ∆C . With this orientation, EGFs I-V wrap back along the WIF domain (Fig. 4a,b) so that residues Phe257 and Ile263 of EGF III make hydrophobic interactions with WIF domain residues Phe100, Leu124 and Met157 (Fig. 3b, asterisk on the 180°  view; Fig. 4d ). Three variants of WIF-1 ∆C with mutations designed to disrupt this interface by introducing N-linked glycosylation sites (Phe100Asn Glu102Ser, Leu124Asn and Met157Asn) did not show impaired inhibitory function (Figs. 3a, 4d) , arguing against the idea that the hydrophobic patch is directly involved in Wnt3a recognition. The interface between the WIF domain and EGF III is not extensive (total buried surface area 260 Å 2 , calculated with PISA 23 ), but it does serve to define a preferred relative orientation between the a r t i c l e s WIF domain and EGFs I-V. Several observations suggest that EGFs I-V would have substantial inter-domain flexibility. The different orientation of EGF I in the WIF-1 WD-EGF-I structure indicates that the linker between the WIF domain and EGF I is flexible, and the electron density for EGFs IV-V in the WIF-1 ∆C crystal structure was fragmentary, consistent with considerable flexibility, so we omitted these domains from the final refined coordinates for WIF-1 ∆C . The WD-EGF III interface stabilizes the 'wrapped-back' orientation of the EGF-like domains in the WIF-1 ∆C crystal, and the juxtaposition of the WIF domain and EGFs I-V is consistent with both regions contributing to an extended Wnt3a-binding surface. Thus the structure of WIF-1 ∆C , in combination with the results of the cellular Wnt inhibition assay and solution binding studies, suggest a modular mechanism for Wnt binding that combines sites on the WIF domain and EGFs I-V.
WIF-1 binds glycosaminoglycans via the EGF-like domains
We hypothesized that, in addition to contributing to Wnt binding, EGFs I-V might have a further, distinctive role in Wnt inhibition. Eight evolutionarily conserved arginines and lysines in the sequence of EGF IV (Supplementary Fig. 8a ), when mapped into the modeled structure of the domain, generate a highly positively charged surface (Fig. 5a,b) , suggesting that WIF-1 might bind to highly sulfated, negatively charged glycosaminoglycans (GAGs). We studied interactions between WIF-1 ∆C , WIF-1 WD-EGF-I and four GAGs using the SPR binding assay. Binding was tightest between WIF-1 ∆C and the most sulfated GAG, heparin (K d 2.7 ± 1.5 µM; Fig. 5c ). Binding was weaker between WIF-1 ∆C and the second most sulfated GAG, heparan sulfate (K d 8.0 ± 2.3 µM; Fig. 5d ). We detected no binding between WIF-1 WD-EGF-I and any of the GAGs, suggesting that interactions between GAGs and WIF-1 are mediated by EGFs II-V.
We used WIF-1 WD-EGFs I-III to further define the individual contributions of the EGFs, measuring binding to heparin and heparin sulfate in the SPR assay. The resulting sensorgrams ( Supplementary  Fig. 8b,c) showed qualitatively different binding characteristics from these of WIF-1 ∆C and could not be fitted to a simple 1:1 binding model to give an accurate measure of K d . WIF-1 ∆C did not show detectable binding to the least sulfated GAGs, chondroitin sulfate and chondroitin 4-sulfate. The correlation between higher GAG sulfation and tighter binding to WIF-1 ∆C suggests that electrostatic interactions between negatively charged GAG sulfate groups and positively charged EGF residues are important. Consistent with the SPR binding assay, EGFs I-V and WIF-1 ∆C (but not WIF-1 WD-EGF-I ) bound to a heparin column (Supplementary Fig. 8d ). This binding was disrupted under conditions of low ionic strength (250 mM and 300 mM NaCl for WIF-1 ∆C and EGFs I-V, respectively; Supplementary Fig. 8d) , consistent with the idea that electrostatic interactions are the main drivers of GAG binding. Within EGFs II-V the conserved cluster of lysines and arginines on EGF IV provides the probable focus for the HSPG-binding properties of WIF-1.
DISCUSSION
The WIF domain lipid-binding cavity and interaction with Wnt A solution structure of the refolded human WIF-1 WIF domain provided evidence for a surface interaction between the WIF domain and the single alkyl chain detergent Brij-35 (C 12 H 25 (OCH 2 CH 2 ) n OH, n ≈ 23) that was used in the refolding protocol 9 . This observation raised the possibility that the WIF-1 WIF domain interacted with Wnt3a-linked palmitoyl or palmitoleoyl chains 10, 11 . Our results show a deep hydrophobic pocket in the WIF domain but argue against a binding mode involving insertion of Wnt3a-linked lipid; exchange of the integral WIF-1-bound diacyl lipid with a single-chain Wnt3a-linked lipid would be energetically very unfavorable in the aqueous extracellular environment. Conversely, the WIF domain with diacyl lipid bound lacks an external hydrophobic surface suitable for lipid binding, and we observed no binding of WIF-1 ∆C to 15 different, biologically abundant lipids immobilized on hydrophobic membranes (including examples that were structurally similar to Wnt3a-linked moieties); these observations do not support the existence of interactions between the WIF-1 surface and Wnt3a-linked lipids.
Thus, the WIF-1 WIF domain does not seem to share the characteristics of lipoprotein particles 17 The orientation of the WIF domain is the same as in Figure 1b . Fig. 1c,d ) and WIF-1 WD-EGF-I (green). (d) Hydrophobic contact formed between the WIF domain hydrophobic patch (marked with an asterisk in Fig. 3b , 180° view) and EGF III. Interacting residues are shown as sticks.
a r t i c l e s clearly contributes to the structural integrity of the WIF domain in the crystal structure, but the NMR structure shows that the WIF domain fold is stable in the absence of diacyl phospholipid, albeit in a somewhat collapsed form. Thus, the role of the lipid may not be limited to stabilization of the WIF domain fold. It has been shown that a deletion of two residues (Glu-Leu) in a conserved region of the WIF domain of the Caenorhabditis elegans Wnt receptor RYK LIN-18 abolishes its activity 24 . At the equivalent positions human WIF-1 has Asp54 and Ile55, which mark the entry into the lipid-binding cavity (Supplementary Fig. 3b ). This two-residue deletion might severely disturb the WIF domain structure or lipid binding (or both). Our mapping of the Wnt3a-binding surface is consistent with previous studies 24 in implicating an area of the WIF domain surface close to the lipid head group. The involvement of the lipid in Wnt3a binding might be indirect, through the stabilization of the appropriate protein surface; our results do not provide evidence that the lipid head group makes the major contribution to direct interactions with Wnt3a. One possibility is that the head group contributes to the binding properties of the WIF-1 WIF domain indirectly by providing conformational flexibility, allowing exposure of the appropriate surface on ligand binding. Our results argue for the role of the WD-lipid unit in the protein interactions mediated by WIF-1. Is this likely to be a general characteristic of WD-containing molecules? Sequence analyses have identified WDs in a rather limited number of proteins: WIF-1 in vertebrates, the RYKs (Wnt receptors related to tyrosine kinases), and Shifted (a Hh-binding, rather than Wnt-binding, ortholog of WIF-1 in Drosophila 25, 26 ) (Supplementary Fig. 3b ). For each of these proteins except Shifted, the WD has been identified as a site for protein-protein interactions. Sequence analysis points to conservation of the WD lipid-binding cavity in these proteins, however, further studies will be required to establish whether this lipid-mediated contribution to protein-protein recognition is maintained across the WD family.
The contributions of the EGF-like domains to WIF-1 function
EGFs I-V are required for some aspects of WIF-1 function in vivo. Human WIF-1 blocks Wnt8-dependent axis induction in early Xenopus embryos, and the WIF domain in isolation is as effective as full-length WIF-1 (ref. 7) . However, injections of RNA for chordin (an inhibitor of bone morphogenetic protein function) and full-length WIF-1 produce different morphological effects in the developing Xenopus embryo from injections of chordin and the WIF domain, suggesting that EGFs I-V are essential for the full activity of WIF-1 (ref. 7) . The molecular mechanism(s) by which the EGF-like domains contribute to WIF-1 function have remained obscure. Our results reveal two mechanisms by which EGFs I-V might act. First, EGFs I-V bind directly to Wnt3a in SPR experiments and WIF-1 constructs lacking EGFs I-V, II-V or IV-V inhibit Wnt3a signaling less effectively in a luciferase reporter assay than constructs containing both the WIF domain and EGFs I-V. Thus the EGF-like domains may either contribute a second component to an extended Wnt-binding surface or provide a second, independent site for Wnt binding (Fig. 5e,f) . a r t i c l e s Second, WIF-1 binds directly to heparin and heparan sulfate through EGFs II-V, consistent with a highly conserved cluster of positively charged residues on EGF IV. These observations suggest a potential mechanism by which to link WIF-1 localization and inhibitory activity to morphogen gradients (Fig. 5e,f) .
Genetic studies on Shifted, the Drosophila ortholog of WIF-1, suggest that EGFs I-V mediate interactions with Hh and HSPGs and are required for their colocalization 25, 26 . HSPGs provide a mechanism for localizing proteins and assemblies (for example, lipoprotein particles associated with Wnts and Hhs 17 ) near the target cell surface. Extracellular concentration and Wnt signaling are reduced in Drosophila cells defective for EXT glycosyltransferases, which are required for the synthesis of heparan sulfate 27 , and mutations in human orthologs cause hereditary diseases 28 . Injection of the heparin-degrading enzyme heparinase into wild-type Drosophila embryos results in the degradation of heparin-like GAGs and a wingless-like phenotype 29 .
The ability of WIF-1 to bind GAGs through evolutionarily conserved EGFs provides a mechanism for the localization of WIF-1 and Shifted within Wnt and Hh morphogen gradients, respectively. Several Wnt signaling inhibitors bind to heparin, including sclerostin 30 , Dkk-1 (ref. 31) and sFRP-1 (ref. 32) . Similarly to WIF-1, the two-domain sFRP-1 has been reported to use the N-terminal (cysteine-rich) domain for Wnt binding 33 and the C-terminal (netrin-like) domain for heparin binding 34 . Our structural and functional studies suggest a modular model for human WIF-1 that exemplifies how the interplay between Wnt-and GAG-binding sites in Wnt antagonists might link inhibition to the morphogen gradient. 
METHODS
Methods
